AI Biosciences, Inc. SBIR Phase I Award, September 2022
A SBIR Phase I contract was awarded to AI BIOSCIENCES, INC. in September, 2022 for $299,939.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention.
Currently, there are no issues on this topic.
Find more entities like AI Biosciences, Inc. SBIR Phase I Award, September 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.